Source: Minimum age of 11 set for UK puberty blocker trial – BBC News
Gender-questioning children will have to be at least 11 years old to take part in a clinical trial assessing the risks and benefits of puberty-blocking drugs.
The planned Pathways Trial, external was paused in February 2026 after the Medicines and Healthcare products Regulatory Agency (MHRA) raised safety concerns and suggested introducing a minimum age of 14, where none had been set previously.
Categories: News